{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T05:39:51Z","timestamp":1773207591543,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"45","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Minist\u00e8re de la Sant\u00e9 et des Services sociaux, Quebec"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.09.049","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T15:04:14Z","timestamp":1538060654000},"page":"6688-6694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa\u00ae) and MMRV (ProQuad\u00ae) at 18\u202fmonths of age"],"prefix":"10.1016","volume":"36","author":[{"given":"Marilou","family":"Kiely","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-No\u00eblle","family":"Billard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eveline","family":"Toth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseline G.","family":"Zafack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monique","family":"Landry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta M.","family":"Skowronski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaston","family":"De Serres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.049_b0005","series-title":"Enqu\u00eate sur la couverture vaccinale des enfants de 1 an et 2 ans au Qu\u00e9bec en 2014","author":"Boulianne","year":"2015"},{"key":"10.1016\/j.vaccine.2018.09.049_b0010","unstructured":"Kiely M, Boulianne N, Ouakki M, Audet D, Gari\u00e9py MC, Guay M, et al. Enqu\u00eate sur la couverture vaccinale des enfants de 1 an et 2 ans au Qu\u00e9bec en 2016. Institut national de sant\u00e9 publique du Qu\u00e9bec; 2017 Nov."},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.049_b0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00431-007-0506-z","volume":"166","author":"Zepp","year":"2007","journal-title":"Eur J Pediatr."},{"issue":"11","key":"10.1016\/j.vaccine.2018.09.049_b0020","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00431-002-1079-5","article-title":"Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV\/Hib vaccine compared to separate concomitant injections of DTPa-IPV\/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule","volume":"161","author":"Avdicov\u00e1","year":"2002","journal-title":"Eur J Pediatr"},{"issue":"8","key":"10.1016\/j.vaccine.2018.09.049_b0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/00365540410017572","article-title":"Evaluation of the immunogenicity and reactogenicity of a DTPa-HBV-IPV Combination vaccine co-administered with a Hib conjugate vaccine either as a single injection of a hexavalent combination or as two separate injections at 3, 5 and 11 months of age","volume":"36","author":"Gabutti","year":"2004","journal-title":"Scand J Infect Dis."},{"issue":"20","key":"10.1016\/j.vaccine.2018.09.049_b0030","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.vaccine.2015.02.070","article-title":"Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad \u00ae) administered concomitantly with a booster dose of a hexavalent vaccine in 12\u201323-month-old infants","volume":"33","author":"Deichmann","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.049_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.inf.0000207857.10947.1f","article-title":"Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate\/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines","volume":"25","author":"Shinefield","year":"2006","journal-title":"Pediatr Infect Dis J."},{"issue":"12","key":"10.1016\/j.vaccine.2018.09.049_b0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1097\/01.inf.0000190028.96152.46","article-title":"A modified vaccine reduces the rate of large injection site reactions to the preschool booster dose of diphtheria-tetanus-acellular pertussis vaccine: results of a randomized","volume":"24","author":"Scheifele","year":"2005","journal-title":"Controlled Trial Pediatr Infect Dis J."},{"issue":"6 Pt 1","key":"10.1016\/j.vaccine.2018.09.049_b0045","article-title":"Injection-site reactions to booster doses of acellular pertussis vaccine: rate, severity, and anticipated impact","volume":"112","author":"Skowronski","year":"2003","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.049_b0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.vaccine.2016.12.017","article-title":"Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years","volume":"23","author":"Southern","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2018.09.049_b0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1045-1870(03)00033-5","article-title":"Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines","volume":"14","author":"Rennels","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.049_b0060","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/pch\/14.4.245","article-title":"Vaccination site reaction or bacterial cellulitis","volume":"14","author":"Lapphra","year":"2009","journal-title":"Paediatr Child Health"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.049_b0065","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/21645515.2016.1250049","article-title":"Herpes zoster vaccine (Zostavax\u00ae): cellulitic injection site reaction or bacterial cellulitis?","volume":"13","author":"Cook","year":"2017","journal-title":"Hum Vacc Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2018.09.049_b0070","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006454-199305000-00003","article-title":"Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination","volume":"12","author":"Simon","year":"1993","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2018.09.049_b0075","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1542\/peds.75.2.299","article-title":"Outbreaks of group A streptococcal abscesses following diphtheria-tetanus toxoid-pertussis vaccination","volume":"75","author":"Stetler","year":"1985","journal-title":"Pediatrics"},{"issue":"48","key":"10.1016\/j.vaccine.2018.09.049_b0080","doi-asserted-by":"crossref","first-page":"6360","DOI":"10.1016\/j.vaccine.2014.09.017","article-title":"Vaccine safety implications of Ontario, Canada\u2019s switch from DTaP-IPV to Tdap-IPV for the pre-school booster","volume":"32","author":"Klar","year":"2014","journal-title":"Vaccine."},{"issue":"31","key":"10.1016\/j.vaccine.2018.09.049_b0085","doi-asserted-by":"crossref","first-page":"5803","DOI":"10.1016\/j.vaccine.2007.04.059","article-title":"Cellulitis at injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Halperin","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2018.09.049_b0090","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J."},{"issue":"10","key":"10.1016\/j.vaccine.2018.09.049_b0095","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/oxfordjournals.aje.a117365","article-title":"The effect of disease prior to an outbreak on estimates of vaccine efficacy following the outbreak","volume":"141","author":"Haber","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.09.049_b0100","doi-asserted-by":"crossref","unstructured":"Porgo TV, Gilca V, De Serres G, Tremblay M, Skowronski D. Dramatic reduction in hepatitis B through school-based immunization without a routine infant program in a low endemicity region. BMC Infect Dis [Internet]. [cited 2018 Jul 17] 2015 Dec;15(1). Available from: <http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0979-8>.","DOI":"10.1186\/s12879-015-0979-8"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18313185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T21:29:23Z","timestamp":1662154163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18313185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":20,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18313185"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa\u00ae) and MMRV (ProQuad\u00ae) at 18\u202fmonths of age","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}